Choice of Surgical Procedure for Patients With Non–Small-Cell Lung Cancer ≤ 1 cm or > 1 to 2 cm Among Lobectomy, Segmentectomy, and Wedge Resection: A Population-Based Study
Chenyang Dai(Anhui Medical University), Jianxing He(First Affiliated Hospital of Guangzhou Medical University), Wenhua Liang(First Affiliated Hospital of Guangzhou Medical University), Yijiu Ren(Tongji University), Hui Zheng(Association for Jewish Studies), Calvin S.H. Ng(Johnson & Johnson (United States)), René Horsleben Petersen(Johnson & Johnson (United States)), Yaxing Shen(Johnson & Johnson (United States)), Jiaxi He(Johnson & Johnson (United States)), Alessandro Brunelli(St James's University Hospital), Chang Chen(The First People's Hospital of Shunde), Dong Xie(Shanghai University of Traditional Chinese Medicine), Ping Yang(Zhongshan Hospital), Ke Fei(Tongji University), Jianfei Shen(Wenzhou Medical University), Chia-Chuan Liu(National Cheng Kung University), Gaetano Rocco(Memorial Sloan Kettering Cancer Center), Shengyi Zhong(Zhongshan Hospital), Gening Jiang(Tongji University)
Cited by 245
Related Papers
Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical Trial
|Journal of Clinical Oncology|2018|976
ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)
|European Respiratory Journal|2009|920
Physiologic Evaluation of the Patient With Lung Cancer Being Considered for Resectional Surgery
|CHEST Journal|2013|901
Impact of Examined Lymph Node Count on Precise Staging and Long-Term Survival of Resected Non–Small-Cell Lung Cancer: A Population Study of the US SEER Database and a Chinese Multi-Institutional Registry
|Journal of Clinical Oncology|2017|358
Prospective Study of Bevacizumab Plus Temozolomide in Patients With Advanced Neuroendocrine Tumors
|Journal of Clinical Oncology|2012|301